DCM NOUVELLE Latest Share Price (DCMNVL)
TODAY IN ONE LINE
DCMNVL jumped 3.1% on above-average volume (838100.0x avg), outperforming Nifty's 0.3% move, with no exchange filing today, suggesting a market-driven move.
With a market cap of ₹331.9 Cr., it trades at a P/E of 11.14. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
DCM NOUVELLE flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Promoter HoldingPromoters hold 50.1% skin-in-the-game
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 28.8% YoY
- ●Poor Capital ReturnsLow ROE of 0.5%
- ●Expensive ValuationTrading at a high P/E ratio of 83.4x
Latest DCM NOUVELLE News
What changed recently?
Recent events, corporate actions, and announcements.
DCM NOUVELLE valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for DCM NOUVELLE, framed against the sector median so the premium or discount is obvious at a glance.
DCM NOUVELLE trades at a P/E of 11.14× and P/B of 1.00×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
DCM NOUVELLE technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for DCM NOUVELLE — derived from the latest tape, not yesterday's close.
DCM NOUVELLE last traded at ₹180.2 with an intraday range of ₹172.52–₹182.79 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹180.20| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 205.03 | +24.83 | +13.78% |
| R3 | 194.76 | +14.56 | +8.08% |
| R2 | 188.77 | +8.57 | +4.76% |
| R1 | 184.49 | +4.29 | +2.38% |
| PIVOT | 178.50 | -1.70 | -0.94% |
| CURRENT | 180.20 | — | — |
| S1 | 174.22 | -5.98 | -3.32% |
| S2 | 168.23 | -11.97 | -6.64% |
| S3 | 163.95 | -16.25 | -9.02% |
| S4 | 153.68 | -26.52 | -14.72% |
DCMNVL is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹170.4–₹177.25
Trading Above opening range, showing Bullishness
DCM NOUVELLE financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for DCM NOUVELLE — consolidated or standalone — with margins, YoY growth and key ratios inline.
DCM NOUVELLE reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹331.9 Cr. and reported EPS of ₹14.98.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 1,076 | 1,027 ▼ 4.5% |
| Sales Growth YoY %Derived | -0.47% | -4.54% |
| Other Income | 6 | 1 ▼ 76.8% |
| Total Income | 1,082 | 1,028 ▼ 4.9% |
| 809 | 761 ▼ 6.0% | |
| Gross ProfitDerived | 267 | 267 ▼ 0.2% |
| Gross Margin %Derived | 24.82% | 25.95% |
| 208 | 211 ▲ 1.1% | |
| EBITDA (Operating Profit)Derived | 59 | 56 ▼ 4.6% |
| OPM %Derived | 5.45% | 5.44% |
| 60 | 46 ▼ 23.4% | |
| Profit Before Tax (PBT) | 14 | 7 ▼ 46.2% |
| 8 | 6 ▼ 25.4% | |
| Effective Tax %Derived | 56.15% | 77.81% |
| Total Profit for Period | 6 | 2 ▼ 72.8% |
| Less: Non-controlling Interests | -3 | -2 ▲ 31.8% |
| Net Profit (Owner's PAT)Derived | 9 | 4 ▼ 59.5% |
| Net Profit Margin %Derived | 0.83% | 0.35% |
| PAT Growth YoY %Derived | 372.48% | -59.48% |
| Earnings Per Share (EPS ₹) | 4.77 | 1.93 ▼ 59.5% |
| Diluted Shares Outstanding (Cr) | 2 | 2 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▲ 110.0% |
| Total Expenses (incl. D&A & Interest) | 1,068 | 1,021 ▼ 4.4% |
| Material Cost % of RevenueDerived | 74.71% | 75.29% |
| Employee Cost % of RevenueDerived | 6.43% | 6.98% |
| Other Cost % of RevenueDerived | 12.94% | 13.52% |
| Interest Coverage (x)Derived | 1.12x | 1.42x |
| Period | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|
| Revenue from Operations | 909 | 864 ▼ 4.9% | 1,081 ▲ 25.0% | 1,076 ▼ 0.5% | 1,027 ▼ 4.5% | |
| Sales Growth YoY %Derived | — | -4.94% | 25.05% | -0.47% | -4.54% | |
| Other Income | 8 | 6 ▼ 29.8% | 7 ▲ 14.1% | 6 ▼ 12.0% | 1 ▼ 76.8% | |
| Total Income | 918 | 870 ▼ 5.2% | 1,088 ▲ 25.0% | 1,082 ▼ 0.5% | 1,028 ▼ 4.9% | |
563 | 688 ▲ 22.1% | 855 ▲ 24.3% | 809 ▼ 5.4% | 761 ▼ 6.0% | ||
| Gross ProfitDerived | 346 | 177 ▼ 49.0% | 226 ▲ 28.1% | 267 ▲ 18.0% | 267 ▼ 0.2% | |
| Gross Margin %Derived | 38.05% | 20.43% | 20.93% | 24.82% | 25.95% | |
172 | 145 ▼ 15.5% | 188 ▲ 29.3% | 208 ▲ 11.1% | 211 ▲ 1.1% | ||
| EBITDA (Operating Profit)Derived | 174 | 32 ▼ 81.9% | 39 ▲ 22.2% | 59 ▲ 51.8% | 56 ▼ 4.6% | |
| OPM %Derived | 19.17% | 3.65% | 3.57% | 5.45% | 5.44% | |
19 | 13 ▼ 28.3% | 48 ▲ 263.3% | 60 ▲ 24.3% | 46 ▼ 23.4% | ||
| Profit Before Tax (PBT) | 164 | 18 ▼ 88.9% | -3 ▼ 116.7% | 14 ▲ 551.6% | 7 ▼ 46.2% | |
42 | 7 ▼ 84.2% | 1 ▼ 83.9% | 8 ▲ 627.4% | 6 ▼ 25.4% | ||
| Effective Tax %Derived | 25.30% | 36.04% | -34.87% | 56.15% | 77.81% | |
| Total Profit for Period | 123 | 12 ▼ 90.5% | -4 ▼ 135.2% | 6 ▲ 246.8% | 2 ▼ 72.8% | |
| Less: Non-controlling Interests | — | -1 | -1 ▼ 31.7% | -3 ▼ 248.2% | -2 ▲ 31.8% | |
| Net Profit (Owner's PAT)Derived | 123 | 12 ▼ 90.0% | -3 ▼ 126.6% | 9 ▲ 372.5% | 4 ▼ 59.5% | |
| Net Profit Margin %Derived | 13.48% | 1.42% | -0.30% | 0.83% | 0.35% | |
| PAT Growth YoY %Derived | — | -89.98% | -126.61% | 372.48% | -59.48% | |
| Earnings Per Share (EPS ₹) | 65.64 | 6.57 ▼ 90.0% | -1.75 ▼ 126.6% | 4.77 ▲ 372.6% | 1.93 ▼ 59.5% | |
| Diluted Shares Outstanding (Cr) | 2 | 2 ▲ 0.0% | 2 ▲ 0.0% | 2 ▲ 0.0% | 2 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | -0 | 0 ▲ 144.8% | -0 ▼ 153.8% | 0 ▲ 242.9% | 0 ▲ 110.0% | |
| Total Expenses (incl. D&A & Interest) | 754 | 852 ▲ 13.1% | 1,091 ▲ 28.0% | 1,068 ▼ 2.1% | 1,021 ▼ 4.4% | |
| Material Cost % of RevenueDerived | 65.99% | 81.71% | 77.00% | 74.71% | 75.29% | |
| Employee Cost % of RevenueDerived | 6.02% | 6.00% | 5.59% | 6.43% | 6.98% | |
| Other Cost % of RevenueDerived | 12.86% | 10.78% | 11.76% | 12.94% | 13.52% | |
| Interest Coverage (x)Derived | 26.25x | 3.47x | 0.62x | 1.12x | 1.42x |
DCM NOUVELLE segment analysis : revenue and profit mix.
Disclosed business segments at DCM NOUVELLE with their share of revenue and profit, switchable between consolidated and standalone reporting.
DCM NOUVELLE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for DCM NOUVELLE.
Our AI distills the core fundamental drivers supporting DCM NOUVELLE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
DCM NOUVELLE's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Promoter holding stable at 50.11%, signaling strong founder confidence and long-term commitment.
5-year revenue CAGR of 12.95% demonstrates sustained top-line expansion over medium term.
Operating cash flow of ₹30.71 per share annually shows consistent cash generation capability.
Latest quarterly profit grew 14.24% YoY despite sales decline, indicating operational efficiency gains.
Book value per share ₹175.98 near current price ₹184.96, offering reasonable asset backing.
Key Risks.
TTM EPS declined 28.81% YoY, reflecting significant earnings deterioration and pressure.
ROE of 0.49% and ROCE of 5.18% severely lag industry benchmarks, poor capital efficiency.
P/E ratio of 57.22x far exceeds peer median 25–46x, suggesting overvaluation concerns.
Operating margin of 2.58% critically low versus peer averages 10–16%, weak profitability.
Quarterly sales declined 1.38% YoY despite profit growth, indicating unsustainable margin expansion.
Flip Conditions.
Valuation risk. a P/E above 14 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.48. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
DCM NOUVELLE peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — DCM NOUVELLE is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
DCM NOUVELLE chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for DCM NOUVELLE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
DCM NOUVELLE delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for DCM NOUVELLE over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in DCM NOUVELLE stood at 87.5% of traded volume, against a 20-day average of 70.4%.
DCM NOUVELLE announcements: results, concalls, ratings, M&A.
Filings DCM NOUVELLE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
DCM NOUVELLE files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 52 documents below.
Copy of Newspaper Publication
DCM Nouvelle Limited has informed the Exchange about Copy of Newspaper Publication regarding 10th Annual General Meeting of the Company and…
General Updates
DCM Nouvelle Limited has informed the Exchange about dispatch of physical letters containing Weblink and detailed path for access to Annual Report of…
General Updates
DCM Nouvelle Limited has informed the Exchange regarding submission of Business Responsibility and Sustainability Report of the Company for Financial…
Shareholders meeting
DCM Nouvelle Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on Friday, September 25, 2026 through Video…
Copy of Newspaper Publication
DCM Nouvelle Limited has informed the Exchange about Copy of Newspaper Publication for information regarding 10th Annual General Meeting of the…
Investor decks & rating reports.
DCM NOUVELLE dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue DCM NOUVELLE has declared, sequenced by announce and record date.
DCM NOUVELLE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About DCM NOUVELLE: business, sector, key facts.
What DCM NOUVELLE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
DCM NOUVELLE operates in the Other Textile Products industry under the Textiles sector, listed as NSE: DCMNVL, BSE: 542729.
DCM Nouvelle Limited is a prominent player in the global textile industry, specializing in the manufacturing and sale of high-quality cotton yarn. Its operations span several key markets including India, Bangladesh, China, and Egypt, as well as other international destinations, highlighting a significant global reach and presence within the textile sector. The company's commitment to supplying diverse markets reflects a robust business strategy focused on broad market penetration and diversification.
The company’s business model is structured around two core segments: Textiles and Chemicals. The Textiles segment represents the primary focus, encompassing the production and distribution of a variety of cotton yarns. DCM Nouvelle offers a diverse product portfolio, including yarns categorized as “better cotton initiative,” organic, and slub yarns, catering to a wide range of customer preferences and industry demands. This diversification strategy allows the company to adapt to fluctuating market trends and tap into different niche segments.
Further enhancing its market positioning, DCM Nouvelle Limited markets its products under several established brand names, including PRIMERO, DINERO, CCY, and FUTURO. These brand names contribute to product recognition and differentiation within the competitive cotton yarn market. The use of distinct branding strategies is crucial in effectively communicating product quality, value proposition, and target market appeal, ensuring a strong market identity and consumer loyalty.
Beyond textiles, the Chemicals segment contributes to the company's overall revenue streams. This segment focuses on the manufacturing and sale of specialty chemicals, specifically mentioning benzylamine and dibenzylamine. The inclusion of a chemicals segment demonstrates vertical integration or diversification efforts, potentially providing cost advantages or accessing new market opportunities that align with the company's existing expertise and resources. This strategic diversification mitigates risk associated with relying solely on a single product line or market segment.
Established in 1991 and headquartered in New Delhi, India, DCM Nouvelle Limited possesses a rich history and significant experience within the textile and chemical sectors. Its sustained operations across multiple countries and its diversification into both textiles and chemicals demonstrate a robust and adaptable business model, successfully navigating the complexities of the global market while maintaining a strong market position.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AKSHAR SPINTEX (AKSHAR) Share PricePeer
- ALOK INDUSTRIES (ALOKINDS) Share PricePeer
- AMBIKA COTTON MILL (AMBIKCO) Share PricePeer
- ASHIMA (ASHIMASYN) Share PricePeer
- AXITA COTTON (AXITA) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about DCM NOUVELLE (DCMNVL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of DCM NOUVELLE (DCMNVL)?
The current share price of DCM NOUVELLE (DCMNVL) is ₹180.20. Today, the stock has gained by ₹5.36 (3.07%), trading in a range of ₹172.52 to ₹182.79. The stock opened at ₹175.02 with a trading volume of 8,381 shares.
02Is DCM NOUVELLE stock a good investment for long-term?
DCM NOUVELLE can be considered for long-term investment based on several factors. The company has a market capitalization of ₹331.9 Cr., P/E ratio of 11.14, ROE of 0.49%, and ROCE of 0.89%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of DCM NOUVELLE stock?
The 52-week high price of DCM NOUVELLE (DCMNVL) is ₹198.58, while the 52-week low is ₹95.60. Currently trading at ₹180.20, the stock is 88.49% above its 52-week low and 9.26% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy DCM NOUVELLE stock at the current price?
Whether to buy DCM NOUVELLE stock at ₹180.20 depends on multiple factors. The stock is currently trading with a P/E ratio of 11.14 and P/B ratio of 1. Today's performance shows a gain of 3.07%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of DCM NOUVELLE and when is the next dividend?
DCM NOUVELLE offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹180.20, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of DCM NOUVELLE?
DCM NOUVELLE's key financial metrics include: P/E Ratio: 11.14, P/B Ratio: 1, ROE: 0.49%, ROCE: 0.89%, Dividend Yield: 0%, EPS: ₹14.98, Book Value: ₹178.46, and Debt-to-Equity: 0.98. The company's market cap stands at ₹331.9 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is DCM NOUVELLE stock performing today in the market?
DCM NOUVELLE stock opened at ₹175.02 and is currently trading at ₹180.20, showing a gain of ₹5.36 (3.07%). The intraday high is ₹182.79 and low is ₹172.52. The trading volume stands at 8,381 shares, indicating moderate market participation today.
08What is the P/E ratio of DCM NOUVELLE and what does it indicate?
DCM NOUVELLE has a Price-to-Earnings (P/E) ratio of 11.14, which means investors are willing to pay 11.14 for every ₹1 of earnings. With an EPS of ₹14.98, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about DCM NOUVELLE (DCMNVL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.